London — Royal Dutch Shell more than tripled its profits in the second quarter to beat forecasts, boosted by strong refining operations and a rise in oil prices.

The Anglo-Dutch oil and gas company also reported a huge recovery in cash flow to $12.2bn and a drop in debt as its cost-reduction efforts in recent years paid off. It has sold some $25bn of assets since acquiring BG Group last year.

The strong results came despite a dip in oil and gas production compared to the previous quarter as a result of reduced output from a facility in Qatar. "The external price environment and energy sector developments mean we will remain very disciplined, with an absolute focus on the four levers within our control," CEO Ben van Beurden said.

Shell reiterated its plans to spend about $25bn this year, at the lower end of its long-term range, as oil prices struggle to rise.

Net income attributable to shareholders in the second quarter, based on a current cost of supplies and excluding exceptional items, rose 245% to $3.6bn, topping a company-provided analyst consensus of $3.15bn. The rise in profits was driven mostly by refining and chemicals.

Cash flow in the first half of the year rose seven fold to $20.8bn from a year earlier.

Oil and gas production in the second quarter declined to 3.495-million barrels of oil equivalent per day (boed) from 3.752-million boed in the first quarter.

Shell is one of the top three picks of analysts that cover global oil companies, together with Chevron and Total, Reuters data show. Its disposal programme over the past two years could further impact growth, however. Shell expects a 240,000 barrel-per-day, year-on-year fall in third-quarter production due to divestments in Malaysia and Australia, and the separation of its Motiva asset in the US.

Shell said its debt pile stood at $78bn. Its debt to equity ratio fell for a second consecutive quarter to 25.3% from a peak of 29.2% in the third quarter of 2016 that followed its $54bn acquisition of BG Group.


Please sign in or register to comment.